Načítá se...
Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis
B-cell chronic lymphocytic leukemia (B-CLL) cells are resistant to apoptosis, and consequently accumulate to the detriment of normal B cells and patient immunity. Because current therapies fail to eradicate these apoptosis-resistant cells, it is essential to identify alternative survival pathways as...
Uloženo v:
| Vydáno v: | Oncogene |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5808079/ https://ncbi.nlm.nih.gov/pubmed/29059151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2017.365 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|